| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/11/2009 | CA2707258A1 Device and method for microbiological analysis of biological samples |
| 06/11/2009 | CA2707201A1 G immunoglobulin used against anthrax toxins |
| 06/11/2009 | CA2707076A1 Nogo receptor binding small molecules to promote axonal growth |
| 06/11/2009 | CA2706907A1 Cancer vaccine composition |
| 06/11/2009 | CA2706881A1 Tle3 as a marker for chemotherapy |
| 06/11/2009 | CA2706453A1 Braf biomarkers |
| 06/11/2009 | CA2705792A1 Vegf polymorphisms and anti-angiogenesis therapy |
| 06/11/2009 | CA2702726A1 Semi-conductor transducer, and the use thereof in an electron donor or electron acceptor space sensor |
| 06/10/2009 | EP2068152A1 c-Kit as a novel target for the treatment of pain |
| 06/10/2009 | EP2068151A1 Soluble amyloid precursor proteins in cerebrospinal fluid as biomarkers of Alzheimer's disease |
| 06/10/2009 | EP2068150A1 Method for identifying ester coolers |
| 06/10/2009 | EP2068149A1 Method for determining the toxicity of a toxin or a toxoid |
| 06/10/2009 | EP2068148A1 Method of measuring anticoagulation and reagent for measuring anticoagulation |
| 06/10/2009 | EP2068147A1 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 06/10/2009 | EP2068146A1 Electrically controlled ion transport device |
| 06/10/2009 | EP2067865A1 Biochemical test system, measurement device, and biochemical test strip |
| 06/10/2009 | EP2067862A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/10/2009 | EP2067856A1 Method of proliferating hepatitis virus, hollow fiber for culturing hepatitis virus-infected cells and utilization of the same |
| 06/10/2009 | EP2067855A1 Accumulation and detection of foetal cells in maternal blood |
| 06/10/2009 | EP2067848A1 Instrument for biochemical use having surface under the inhibition of nonspecific adsorption |
| 06/10/2009 | EP2067792A2 Inhibitory antibodies of HER3 activity |
| 06/10/2009 | EP2067790A2 Agonist antibody against protein tyrosine kinase SAL-S1 |
| 06/10/2009 | EP2067788A2 Fab fragment libraries and methods for their use |
| 06/10/2009 | EP2067783A1 Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof |
| 06/10/2009 | EP2067489A1 Glyco-molecular imaging method for grade classification of liver fibrosis and its glyco-molecular imaging agent thereof |
| 06/10/2009 | EP2067480A1 Musclin receptor and use thereof |
| 06/10/2009 | EP2067045A1 A method of diagnosis and kit therefor |
| 06/10/2009 | EP2067044A1 Anti-drug antibody assay |
| 06/10/2009 | EP2067043A2 Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers |
| 06/10/2009 | EP2067042A2 Means and methods for diagnosing and/or treating a subject at risk of developing heart failure |
| 06/10/2009 | EP2067041A2 Biomarkers and assays for the treatment of cancer |
| 06/10/2009 | EP2067040A2 Use of at least one isoform of progesterone receptor membrane component 1 (pgrmc1) |
| 06/10/2009 | EP2067039A2 Non-neuroendocrine cancer therapy |
| 06/10/2009 | EP2067038A1 Methods of selecting cell clones |
| 06/10/2009 | EP2067037A2 Diagnosis of fasciolosis by skin test (intradermoreaction) using the antigen fh8 (fasciolin) |
| 06/10/2009 | EP2067036A2 Ehrlicia canis diva (differentiate infected from vaccinated animals) |
| 06/10/2009 | EP2067035A2 Surface mapping by optical manipulation of particles in relation to a functionalized surface |
| 06/10/2009 | EP2067034A2 Eif4e regulon-based diagnostics |
| 06/10/2009 | EP2067033A1 Method for ensuring the safety of the components of the drive train of a vehicle following the deterioration of the fuel |
| 06/10/2009 | EP2067032A2 An apparatus and method for determining the percentage of carbon equivalent, carbon and silicon in liquid ferrous metal |
| 06/10/2009 | EP2067031A1 Rapid in vivo model for angiogenesis |
| 06/10/2009 | EP2067026A1 Apparatus and method for well services fluid evaluation using x-rays |
| 06/10/2009 | EP2067018A2 A sensor device for and a method of sensing particles |
| 06/10/2009 | EP2066816A1 Methods of detecting and monitoring cancer using 3d analysis of centromeres |
| 06/10/2009 | EP2066813A2 Compositions and methods for biodetection by nucleic acid-templated chemistry |
| 06/10/2009 | EP2066812A2 Compositions and methods related to protein displacement therapy for myotonic distrophy |
| 06/10/2009 | EP2066803A2 Fluorescent proteins for monitoring intracellular superoxide production |
| 06/10/2009 | EP2066802A1 Device, system and assay for measuring cell motility |
| 06/10/2009 | EP2066801A1 Determination of hydrogen peroxide concentrations |
| 06/10/2009 | EP2066777A2 Reducing optical interference in a fluidic device |
| 06/10/2009 | EP2066709A1 Particles and their use in a method for isolating nucleic acid or a method for isolating phosphoproteins |
| 06/10/2009 | EP2066692A1 Means and methods for the production of amyloid oligomers |
| 06/10/2009 | EP2066419A1 Chromatography ligand comprising domain c from staphyloccocus aureus protein a for antibody isolation |
| 06/10/2009 | EP2066236A2 Device for fractionating expiration volume |
| 06/10/2009 | EP2010912A4 Predicting mortality and detecting severe disease |
| 06/10/2009 | EP1991704A4 Signal amplification of biorecognition events using photopolymerization in the presence of air |
| 06/10/2009 | EP1956977A4 Flexible apparatus and method for monitoring and delivery |
| 06/10/2009 | EP1951913A4 Process to detect binding events on an electrode microarray using enzymes |
| 06/10/2009 | EP1913385A4 Tissue carbohydrate compositions and analysis thereof |
| 06/10/2009 | EP1877559A4 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
| 06/10/2009 | EP1838845A4 Continuous flow chamber device for separation, concentration, and/or purification of cells |
| 06/10/2009 | EP1805513A4 Migration inhibitory factor in serum as a tumor marker for prostate, bladder, breast, ovarian, kidney and lung cancer |
| 06/10/2009 | EP1738168A4 Pattern recognition method for diagnosis of systemic autoimmune diseases |
| 06/10/2009 | EP1733437A4 Immunoassay reagents and methods of use thereof |
| 06/10/2009 | EP1714151A4 Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity |
| 06/10/2009 | EP1712638B1 Specific marker Lmx1a on dopaminergic neurons |
| 06/10/2009 | EP1673626A4 Method and apparatus for analysis of molecular combination based on computations of shape complementarity using basis expansions |
| 06/10/2009 | EP1595950B9 Method of measuring homocysteine |
| 06/10/2009 | EP1575981B1 Angiogenic acting tri-sulphate steroids and uses thereof |
| 06/10/2009 | EP1573016A4 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein |
| 06/10/2009 | EP1540329A4 Drug discovery method |
| 06/10/2009 | EP1482961B1 Use of soluble fgl2 as an immunosuppressant |
| 06/10/2009 | EP1437591B1 Method for diagnosing kidney diseases |
| 06/10/2009 | EP1327147B1 Neurotransmission disorders |
| 06/10/2009 | EP1309865B1 Moving droplet diagnostic assay |
| 06/10/2009 | EP1294899B1 16836, a human phospholipase c family member and uses thereof |
| 06/10/2009 | EP1242626B1 Detection of nucleic acids |
| 06/10/2009 | EP1062366B1 Detection of neoplasia by analysis of saliva |
| 06/10/2009 | EP1007570B1 Monospecific antibody reactive with fibrinogen and fibrinopeptide b |
| 06/10/2009 | EP0902893B1 Means for the biological purification of a biological fluid |
| 06/10/2009 | DE202008010042U1 System mit einem leichten Fallgewichtsgerät und einer Messauswertungseinrichtung System with a light weight device case and a measurement evaluation device |
| 06/10/2009 | DE10302888B4 Vorrichtung zur Bestimmung der Konzentration von Härtebildnern und Verfahren zur Prozeßsteuerung Apparatus for determining the concentration of hardness salts and methods for process control |
| 06/10/2009 | DE102008010107A1 Fuel i.e. diesel, classifying method for internal-combustion engine, involves determining frequency component, and assigning fuel in one fuel class based on characteristic that is phase assigned to component |
| 06/10/2009 | DE102007059199A1 Hautmodell Skin model |
| 06/10/2009 | DE102007059167A1 Pipette tip for use in e.g. pipetting device in laboratory, has wall comprising transparent region, where transparent region is formed as coplanar measuring windows in optical quality |
| 06/10/2009 | DE102007059166A1 Vorrichtung zur Messung von Transportsystemen Device for measuring transport systems |
| 06/10/2009 | DE102007058718A1 Vorrichtung und Verfahren zur automatischen Freisetzung und Messung von Wirkstoffen aus einer Arzneizubereitung Apparatus and method for automatic release and measurement of active ingredients from a pharmaceutical preparation |
| 06/10/2009 | CN201255743Y Coal mine well port wine detection instrument |
| 06/10/2009 | CN201255742Y Multifunctional dry plate detection board |
| 06/10/2009 | CN201255741Y Sample fast detecting apparatus |
| 06/10/2009 | CN201255740Y Hematometer |
| 06/10/2009 | CN201255739Y Rubber machining analyzer |
| 06/10/2009 | CN201255738Y Crane constant pressure structure for track instrument |
| 06/10/2009 | CN201255737Y Chemical fiber oil solution applying instrument |
| 06/10/2009 | CN101454673A Sparc and methods of use thereof |
| 06/10/2009 | CN101454672A Method for genetic selection of high-plasmid producing e. coli clones |
| 06/10/2009 | CN101454671A Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 06/10/2009 | CN101454670A Method for measuring human megalin |
| 06/10/2009 | CN101454669A Biological load indicator and method of measuring biological load |
| 06/10/2009 | CN101454668A Methods for prediction and prognosis of cancer, and monitoring cancer therapy |